Sachdev Amit

EVP Chief Patient & Ext Af OffVERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed Feb 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$27.5M
Net Open-Market Flow
-$27.5M
Transactions
12
10 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2026Sell(S)3K$465.05$1.3M114K
Feb 19, 2026Sell(S)4K$471.43$2.0M59K
Feb 19, 2026Option exercise(M)23K$155.57$3.7M93K
Feb 19, 2026Option exercise(M)25K$187.53$4.7M118K
Feb 19, 2026Sell(S)920$463.91$427K117K
Feb 19, 2026Sell(S)2K$465.80$861K112K
Feb 19, 2026Sell(S)10K$467.75$4.8M102K
Feb 19, 2026Sell(S)20K$468.57$9.2M82K
Feb 19, 2026Sell(S)7K$469.61$3.4M75K
Feb 19, 2026Sell(S)12K$470.54$5.5M63K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 19, 2026Option exercise(M)25K$00
Feb 19, 2026Option exercise(M)23K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000102) within minutes of acceptance. Every field above traces to the original document. Verify it directly: